Cumberland Pharmaceuticals CPIX Business Segments
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Revenue by Product | ||||||
| Acetadote | $408.79K-19.6% | $508.46K+5.5% | $482K+18.5% | $406.78K+58.5% | $256.63K+38.6% | |
| Caldolor | $4.32M-7.3% | $4.66M-9.3% | $5.14M-7.3% | $5.54M+15.5% | $4.8M-3.3% | |
| Kristalose | $8.04M-23.7% | $10.54M-10.6% | $11.8M-17.2% | $14.25M-8.7% | $15.6M+1.9% | |
| Other revenue | $1.15M-72.1% | $4.13M-0.8% | $4.16M-7.1% | $4.48M+6.6% | $4.2M+215% | |
| Sancuso | $12.58M+5.6% | $11.91M+8.3% | $11M+6.1% | $10.36M+9.9% | $9.43M+4.8% | |
| Vibativ | $10.23M-7.9% | $11.11M+7.1% | $10.37M+17.8% | $8.8M+2.9% | $8.55M+19.5% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Cumberland Pharmaceuticals break its business down?
- Cumberland Pharmaceuticals (CPIX) reports revenue by product across 7 parts — Acetadote, Caldolor, Kristalose, Other revenue and Sancuso. Each is extracted from the segment footnotes and tracked over time.
- Where does Cumberland Pharmaceuticals's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Cumberland Pharmaceuticals's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
